If you’ve landed here searching for “ICD for anemia from causes to cutting-edge treatment,” you’re likely trying to connect the dots between how anemia is classified in the medical system and what that classification actually means for diagnosis and care. Here’s the short version: ICD-10 codes for anemia span D50 through D64, and each code tells a specific clinical story — from iron deficiency (D50) to anemia in chronic disease (D63) to aplastic anemia (D61). These aren’t just billing numbers. They drive treatment decisions, insurance approvals, and epidemiological tracking worldwide.
What makes anemia coding genuinely useful is that it forces clinicians to identify the why behind a low hemoglobin. A hemoglobin of 9.2 g/dL means very different things depending on whether it’s caused by heavy menstrual bleeding, chronic kidney disease, or myelodysplastic syndrome. The ICD code captures that distinction, and the treatment that follows is entirely different in each case.
ICD-10 Codes for Anemia: The Complete Breakdown
The ICD-10-CM (Clinical Modification) system groups anemia codes into a logical hierarchy. Here’s a reference table of the major categories you’ll encounter in clinical practice and medical billing:
| ICD-10 Code | Anemia Type | Common Example |
|---|---|---|
| D50 | Iron deficiency anemia | Chronic blood loss, poor dietary intake |
| D51 | Vitamin B12 deficiency anemia | Pernicious anemia, malabsorption |
| D52 | Folate deficiency anemia | Pregnancy-related, alcoholism |
| D53 | Other nutritional anemias | Protein deficiency, scurvy-related |
| D55–D59 | Hemolytic anemias | G6PD deficiency, autoimmune hemolysis, sickle cell |
| D60 | Acquired pure red cell aplasia | Parvovirus B19 infection, thymoma |
| D61 | Aplastic anemia | Drug-induced, idiopathic |
| D62 | Acute posthemorrhagic anemia | Trauma, surgical blood loss |
| D63 | Anemia in chronic diseases | Chronic kidney disease, cancer, rheumatoid arthritis |
| D64 | Other anemias | Sideroblastic anemia, anemia NOS |
A critical coding nuance: D63 codes require an underlying condition coded first. For instance, anemia due to stage 4 chronic kidney disease would be coded as N18.4 (CKD stage 4) followed by D63.1. Getting this wrong creates claim denials and delays care.
What Causes Anemia? Mapping Causes to Codes
Anemia affects roughly 1.8 billion people globally, according to WHO data, making it the most common blood disorder on the planet. The causes break into three broad mechanistic categories:
1. Decreased Red Blood Cell Production
- Nutritional deficiency — iron, B12, or folate (codes D50–D53)
- Bone marrow failure — aplastic anemia, myelodysplastic syndromes (D61)
- Chronic disease suppression — inflammatory cytokines blunt erythropoietin response (D63)
- Chronic kidney disease — decreased erythropoietin production (D63.1)
2. Increased Red Blood Cell Destruction (Hemolysis)
- Inherited — sickle cell disease (D57), thalassemia (D56), G6PD deficiency (D55)
- Acquired — autoimmune hemolytic anemia (D59.1), mechanical valve hemolysis, TTP
3. Blood Loss
- Acute — trauma, GI bleed, postpartum hemorrhage (D62)
- Chronic — heavy menstrual bleeding, colon polyps, occult GI blood loss (D50.0)
Iron deficiency alone accounts for approximately 50% of all anemia cases worldwide. In premenopausal women, the prevalence of iron deficiency anemia runs between 10–20% in developed countries and significantly higher in low-resource settings.
Diagnosis: What Tests Actually Matter
The diagnostic workup follows a logical cascade. It starts broad and narrows based on initial findings.
A complete blood count (CBC) is always step one. The WHO defines anemia as hemoglobin below 13.0 g/dL in men and below 12.0 g/dL in non-pregnant women. From there, the mean corpuscular volume (MCV) separates anemia into three buckets:
| MCV Range | Classification | Most Likely Causes |
|---|---|---|
| < 80 fL | Microcytic | Iron deficiency, thalassemia, lead poisoning, sideroblastic anemia |
| 80–100 fL | Normocytic | Chronic disease, acute blood loss, mixed deficiency, bone marrow disorders |
| > 100 fL | Macrocytic | B12/folate deficiency, liver disease, hypothyroidism, MDS, alcohol use |
After MCV-based classification, targeted labs include:
- Ferritin — the single best screening test for iron deficiency. A ferritin below 30 ng/mL is diagnostic; below 15 ng/mL is virtually 100% specific.
- Reticulocyte count — tells you whether the bone marrow is responding appropriately. A low reticulocyte count with anemia suggests a production problem.
- Peripheral blood smear — reveals morphological clues like target cells (thalassemia), schistocytes (TTP/HUS), or spherocytes (hereditary spherocytosis).
- Iron studies panel — serum iron, TIBC, transferrin saturation. A transferrin saturation below 20% supports iron deficiency.
- B12 and folate levels — particularly in macrocytic anemia. Methylmalonic acid and homocysteine help distinguish the two.
- Bone marrow biopsy — reserved for unexplained cytopenias, suspected aplastic anemia, or myelodysplastic syndromes.
Cutting-Edge Treatments: What’s Changed in 2024
Anemia treatment has evolved dramatically beyond “take an iron pill.” Here’s what’s actually new and meaningful:
Iron Deficiency Anemia
Ferric derisomaltose (Monoferric) allows a full iron replacement dose — up to 1,000 mg — in a single 15-minute infusion. This is a game-changer for patients who can’t tolerate oral iron or need rapid correction. Older IV formulations like iron sucrose required multiple visits.
Anemia of Chronic Kidney Disease
HIF-prolyl hydroxylase inhibitors (HIF-PHIs) like roxadustat, daprodustat, and vadadustat represent the first new drug class for renal anemia in over 30 years. These oral medications stimulate endogenous erythropoietin production by mimicking the body’s hypoxia response. Daprodustat (Jesduvroq) received FDA approval in 2023 for CKD patients on dialysis, offering an oral alternative to injectable ESAs.
Sickle Cell Disease
December 2023 marked a historic milestone: FDA approval of exagamglogene autotemcel (Casgevy), the first CRISPR-based gene therapy for sickle cell disease. In clinical trials, 97% of patients were free from vaso-occlusive crises for at least 12 months post-treatment. Lovotibeglogene autotemcel (Lyfgenia), a lentiviral gene therapy, was approved simultaneously.
Myelodysplastic Syndromes (MDS)
Luspatercept (Reblozyl) — an activin receptor ligand trap — reduces transfusion burden in lower-risk MDS patients with ring sideroblasts. The COMMANDS trial showed superiority over erythropoiesis-stimulating agents as first-line therapy, with 59% of patients achieving transfusion independence versus 31% with epoetin alfa.
When to See a Doctor
Don’t wait for severe symptoms to get evaluated. See your doctor if you experience:
- Persistent fatigue that isn’t explained by poor sleep or stress
- Noticeable pallor in your skin, nail beds, or inner eyelids
- Shortness of breath with activities that previously felt easy
- Heart palpitations or a racing pulse at rest
- Pica (craving ice, dirt, or starch) — a surprisingly specific sign of iron deficiency
- Dark or tarry stools, or visible blood in stool or urine
If your hemoglobin drops below 7.0 g/dL, most guidelines recommend red blood cell transfusion, though the threshold varies based on symptoms and cardiac history. Symptomatic patients or those with active coronary disease may need transfusion at higher hemoglobin levels.
Frequently Asked Questions
What is the most commonly used ICD-10 code for anemia?
D64.9 (anemia, unspecified) is the most frequently billed code, but it’s also the least informative. Whenever possible, clinicians should code to the highest specificity — for example, D50.9 for iron deficiency anemia, unspecified, or D51.0 for pernicious anemia. Payers increasingly reject D64.9 without supporting documentation.
Can anemia be cured, or is it always chronic?
It depends entirely on the cause. Iron deficiency from a correctable source (like dietary change or treating a bleeding polyp) can be completely cured. Anemia from chronic kidney disease or inherited conditions like thalassemia major typically requires lifelong management. The new gene therapies for sickle cell disease are the closest we’ve come to a true cure for a genetic anemia.
How do ICD codes affect my treatment or insurance coverage?
Significantly. The ICD code on your chart determines which treatments insurers will approve. For example, IV iron infusions are often only covered when the code specifies iron deficiency anemia (D50) plus documentation of oral iron intolerance. A generic D64.9 code can trigger claim denials. If your treatment is being denied, ask your doctor to review the ICD code being used.
What hemoglobin level qualifies as severe anemia?
The WHO classifies anemia severity as follows: mild (11.0–12.9 g/dL in men, 11.0–11.9 g/dL in women), moderate (8.0–10.9 g/dL), and severe (below 8.0 g/dL). Hemoglobin below 5.0 g/dL is life-threatening and constitutes a medical emergency.
Is anemia of chronic disease the same as iron deficiency anemia?
No, and confusing the two is one of the most common clinical errors. In anemia of chronic disease (D63), the body has adequate iron stores, but inflammatory cytokines — particularly hepcidin — block iron from being used effectively. Ferritin is typically normal or elevated, while transferrin saturation is low. Giving iron in this situation can cause iron overload. Treatment targets the underlying inflammatory condition, not iron supplementation.
